Framingham risk functions are widely used for prediction of future cardiovascular disease events. They do not, however, include anthropometric measures of overweight or obesity, now considered a major cardiovascular disease risk factor. We aimed to establish the most appropriate anthropometric index and its optimal cutoff point for use as an ancillary measure in clinical practice when identifying people with increased absolute cardiovascular risk estimates.
Design
Analysis of a population-based, cross-sectional survey was carried out.
Methods
The 1991 Framingham prediction equations were used to compute 5 and 10-year risks of cardiovascular or coronary heart disease in 7191 participants from the Australian Diabetes, Obesity and Lifestyle Study (1999-2000). Receiver operating characteristic curve analysis was used to compare measures of body mass index (BMI), waist circumference, and waist-to-hip ratio in identifying participants estimated to be at ‘high’, or at ‘intermediate or high’ absolute risk.
Results
After adjustment for BMI and age, waist-to-hip ratio showed stronger correlation with absolute risk estimates than waist circumference. The areas under the receiver operating characteristic curve for waist-to-hip ratio (0.67-0.70 in men, 0.64-0.74 in women) were greater than those for waist circumference (0.60-0.65, 0.59-0.71) or BMI (0.52-0.59, 0.53-0.66). The optimal cutoff points of BMI, waist circumference and waist-to-hip ratio to predict people at ‘high’, or at ‘intermediate or high’ absolute risk estimates were 26kg/m2, 95 cm and 0.90 in men, and 25-26 kg/m2, 80-85 cm and 0.80 in women, respectively.
World Health Organization.The world health report 2004: changing history. Geneva, Switzerland: World Health Organization; 2004.
2.
World Health Organization.Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity, Geneva 3-5 June 1997. Geneva, Switzerland: World Health Organization; 1998. (Publication no. WHO/NUT/NCD/98.1).
3.
StamlerJStamlerRNeatonJD.Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med1993; 153: 598–615.
4.
StamlerJWentworthDNeatonJD.Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356 222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA1986; 256: 2823–2828.
5.
StrattonIMAdlerAINeilHAMatthewsDRManleySECullCA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ2000; 321: 405–412.
6.
Asia Pacific Cohort Studies Collaboration.Body mass index and cardiovascular disease in the Asia-Pacific region: an overview of 33 cohorts involving 310000 participants. Int J Epidemiol2004; 33: 751–758.
7.
AndersonKMOdellPMWilsonPWKannelWB.Cardiovascular disease risk profiles. Am Heart J1991; 121: 293–298.
8.
KnuimanMWVuHT.Prediction of coronary heart disease mortality in Busselton, Western Australia: an evaluation of the Framingham, national health epidemiologic follow up study, and WHO ERICA risk scores. J Epidemiol Community Health1997; 51: 515–519.
9.
WilsonPWFEvansJC.Coronary artery disease prediction. Am J Hypertens1993; 6: S309–S313.
10.
DunstanDWZimmetPZWelbornTACameronAJShawJde CourtenM, et al. The Australian Diabetes, Obesity and Lifestyle Study (AusDiab)- methods and response rates. Diabetes Res Clin Pract2002; 57: 119–129.
11.
HaffnerSMLehtoSRonnemaaTPyoralaKLaaksoM.Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med1998; 339: 229–234.
12.
StevensRJKothariVAdlerAIStrattonIM, United Kingdom Prospective Diabetes Study (UKPDS) Group. The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56). Clin Sci (Lond)2001; 101: 671–679.
13.
World Health Organization Department of Noncommunicable Disease Surveillance.Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Geneva, Switzerland: World Health Organization; 1999. (Publication no. WHO/NCD/NCS/99.2).
14.
RoseGABlackburnH.Cardiovascular surveymethods. Geneva, Switzerland: World Health Organization; 1968.
15.
SchistermanEFPerkinsNJLiuABondellH.Optimal cut-point and its corresponding Youden index to discriminate individuals using pooled blood samples. Epidemiology2005; 16: 73–81.
16.
CalleEEThunMJPetrelliJMRodriguezCHeathCWJr.Body-mass index and mortality in a prospective cohort of US cohorts. N Engl J Med1999; 341: 1097–1105.
17.
WelbornTADhaliwalSSBennettSA.Waist-hip ratio is the dominant risk factor predicting cardiovascular death in Australia. Med J Aust2003; 179: 580–585.
18.
SilventoinenKJousilahtiPVartiainenETuomilehtoJ.Appropriateness of anthropometric obesity indicators in assessment of coronary heart disease risk among Finnish men and women. Scand J Public Health2003; 31: 283–290.
19.
VagueJ.The degree of masculine differentiation of obesities: a factor determining predisposition to diabetes, atherosclerosis, gout, and uric calculous disease. Am J Clin Nutr1956; 4: 20–34.
20.
StolkRPSuriyawongpaisalPAekplakornWWoodwardMNealB, InterASIA Collaborative Group Fat distribution is strongly associated with plasma glucose levels and diabetes in Thai adults: the InterASIA study. Diabetologia2005; 48: 657–660.
21.
ReederBASenthilselvanADespresJPAngelALiuLWangH, et al. The association of cardiovascular disease risk factors with abdominal obesity in Canada. CMAJ1997; 157 (Suppl 1): S39–S45.
22.
YusufSHawkenSOunpuuSBautistaLFranzosiMGCommerfordP, et al. Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study. Lancet2005; 366: 1640–1649.
23.
IDF Epidemiology Task Force Consensus Group.The metabolic syndrome: a new worldwide definition. Lancet2005; 366: 1059–1062.
